Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PleXus Health Science was a U.S.-based health technology company focused on ultraviolet sanitization devices for healthcare, laboratory, workplace, and public settings. Its primary product was the PleXus UVC-650, a mobile UV-C disinfection device marketed to reduce microorganisms, including SARS-CoV-2, across interior spaces. The company appears to have operated as an early-stage, unfunded medical-device style business rather than a therapeutics developer, with no disclosed drug pipeline or clinical-stage pharmaceutical assets. Publicly available records indicate the Florida corporate entity was formed in 2020 in Boca Raton, Florida, and later became inactive. Overall, this is best characterized as a small healthcare-adjacent infection-control device company rather than a biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PleXus Health Science.